Table 4.
| YEAR 3 | Risk Estimate, % (95% Confidence Interval) | |||||
|---|---|---|---|---|---|---|
| Margins ≤2 | Margins>2 | |||||
| Prostate weight >30g | Prostate weight ≤ 30g | Prostate weight >30g | Prostate weight ≤ 30g | |||
| Age ≤ 60 | PSA ≤10 ng/mL | Gleason score ≤3+4 | 87 (83–91) | 78 (72–85) | 76 (68–83) | 62 (52–73) |
| Gleason score 4+3 | 80 (72–89) | 68 (56–82) | 64 (52–80) | 46 (32–68) | ||
| Gleason score 8–10 | 73 (63–85) | 59 (46–75) | 54 (41–72) | 35 (22–56) | ||
| PSA>10 ng/mL | Gleason score ≤3+4 | 80 (73–87) | 67 (58–79) | 64 (54–75) | 47 (34–62) | |
| Gleason score 4+3 | 70 (59–83) | 54 (40–74) | 50 (36–69) | 30 (17–54) | ||
| Gleason score 8–10 | 61 (49–76) | 43 (28–64) | 38 (25–58) | 19 (9–40) | ||
| Age > 60 | PSA 10 ≤ng/mL | Gleason score ≤3+4 | 80 (75–85) | 68 (60–77) | 64 (56–74) | 47 (36–61) |
| Gleason score 4+3 | 70 (61–81) | 54 (41–72) | 50 (37–68) | 30 (17–54) | ||
| Gleason score 8–10 | 61 (51–74) | 43 (30–61) | 38 (26–57) | 19 (9–39) | ||
| PSA>10 ng/mL | Gleason score ≤3+4 | 70 (63–78) | 54 (43–68) | 50 (39–62) | 30 (19–48) | |
| Gleason score 4+3 | 57 (45–72) | 38 (24–60) | 33 (21–53) | 15 (6–37) | ||
| Gleason score 8–10 | 46 (34–62) | 26 (15–47) | 22 (12–39) | 7 (2–23) | ||